The present invention relates to a method for determining likelihood of an individual of developing a psychiatric disorder. More particularly, the method of the invention is based on the identification of genetic variations in genes involved in the modulation of melatonin and their consequences on such pathway for the determination of wether an individual is susceptible of being afflicted by a psychiatric disorder such as autism spectrum disorders (ASD), Attention Deficits and Hyper Activity Disorder (ADHD) and anorexia.
GENETIC VARIATIONS ASSOCIATED WITH PSYCHIATRIC DISORDERS